172 related articles for article (PubMed ID: 29650474)
1. Current trends in the medical management of osteoradionecrosis using triple therapy.
Dhanda J; Rennie L; Shaw R
Br J Oral Maxillofac Surg; 2018 Jun; 56(5):401-405. PubMed ID: 29650474
[TBL] [Abstract][Full Text] [Related]
2. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.
Delanian S; Chatel C; Porcher R; Depondt J; Lefaix JL
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):832-9. PubMed ID: 20638190
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
McCaul JA
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):247-52. PubMed ID: 24794269
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.
Robard L; Louis MY; Blanchard D; Babin E; Delanian S
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):333-338. PubMed ID: 24993781
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review.
Martos-Fernández M; Saez-Barba M; López-López J; Estrugo-Devesa A; Balibrea-Del-Castillo JM; Bescós-Atín C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):431-439. PubMed ID: 29550081
[TBL] [Abstract][Full Text] [Related]
6. New perspectives on the conservative management of osteoradionecrosis of the mandible: A literature review.
Costa DA; Costa TP; Netto EC; Joaquim N; Ventura I; Pratas AC; Winckler P; Silva IP; Pinho AC; Sargento IG; Guerreiro FG; Moreira AR
Head Neck; 2016 Nov; 38(11):1708-1716. PubMed ID: 27240248
[TBL] [Abstract][Full Text] [Related]
7. Protocol for prospective randomised assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline+TOcopherol± CLOdronate for the management of early osteoradionecrosis of the mandible.
Bulsara VM; Bulsara MK; Lewis E
BMJ Open; 2019 Mar; 9(3):e026662. PubMed ID: 30837258
[TBL] [Abstract][Full Text] [Related]
8. The management of osteoradionecrosis of the jaws--a review.
Rice N; Polyzois I; Ekanayake K; Omer O; Stassen LF
Surgeon; 2015 Apr; 13(2):101-9. PubMed ID: 25084627
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pentoxifylline-tocopherol-clodronate in mandibular osteoradionecrosis.
Dissard A; P Dang N; Barthelemy I; Delbet C; Puechmaille M; Depeyre A; Pereira B; Martin F; Guillemin F; Biau J; Mirafzal S; Mom T; Gilain L; Saroul N
Laryngoscope; 2020 Nov; 130(11):E559-E566. PubMed ID: 31747060
[TBL] [Abstract][Full Text] [Related]
10. [Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].
Dutheil F; Guillemin F; Biau J; Pham-Dang N; Saroul N; Clavère P; Lapeyre M
Cancer Radiother; 2021 Jul; 25(5):484-493. PubMed ID: 33836955
[TBL] [Abstract][Full Text] [Related]
11. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.
Rivero JA; Shamji O; Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):464-471. PubMed ID: 29103566
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline-tocopherol-clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone.
Glicksman JT; Khalili S; Fung K; Parnes LS; Agrawal SK
Head Neck; 2015 Dec; 37(12):E191-3. PubMed ID: 25821165
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of pentoxifylline/tocopherol combination in the treatment of osteoradionecrosis.
Hayashi M; Pellecer M; Chung E; Sung E
Spec Care Dentist; 2015; 35(6):268-71. PubMed ID: 26084886
[TBL] [Abstract][Full Text] [Related]
14. Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis.
Kolokythas A; Rasmussen JT; Reardon J; Feng C
Int J Oral Maxillofac Surg; 2019 Feb; 48(2):173-180. PubMed ID: 30205911
[TBL] [Abstract][Full Text] [Related]
15. Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit.
D'Souza J; Lowe D; Rogers SN
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):356-62. PubMed ID: 24480621
[TBL] [Abstract][Full Text] [Related]
16. The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
Patel S; Patel N; Sassoon I; Patel V
Radiother Oncol; 2021 Mar; 156():209-216. PubMed ID: 33385466
[TBL] [Abstract][Full Text] [Related]
17. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis.
Patel V; Gadiwalla Y; Sassoon I; Sproat C; Kwok J; McGurk M
Br J Oral Maxillofac Surg; 2016 Apr; 54(3):342-5. PubMed ID: 26794083
[TBL] [Abstract][Full Text] [Related]
18. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial.
Delanian S; Depondt J; Lefaix JL
Head Neck; 2005 Feb; 27(2):114-23. PubMed ID: 15641107
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience.
McLeod NM; Pratt CA; Mellor TK; Brennan PA
Br J Oral Maxillofac Surg; 2012 Jan; 50(1):41-4. PubMed ID: 21247671
[TBL] [Abstract][Full Text] [Related]
20. Challenges threaten, opportunity awaits hyperbaric medicine and the head and neck cancer patient.
Clarke R
Undersea Hyperb Med; 2019 Jun-Jul-Aug - Third Quarter; 46(4):385-397. PubMed ID: 31509895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
